484 Results (Page 10 of 20)
UAE Markets Research Reports
UAE Transthyretin Amyloidosis (ATTR) Market Analysis
UAE Transthyretin Amyloidosis (ATTR) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transthyretin Amyloidosis (ATTR) market is growing globally due to the increase in disease awareness, advancements in diagnostic techniques, development of disease-modifying therapies, growing investment in research and development, regulatory support and expedited approvals, collaboration and partnerships between pharmaceutical companies and academic institutions. Pfizer Inc, AstraZeneca, Prothena Corporation plc, Ionis Pharmaceuticals, BELLUS Health Inc , Alnylam Pharmaceuticals, Inc, Eidos Therapeutics, Inc, SOM BIOTECH, Abbvie, Inc., Bausch Health Companies Inc., Bristol Myers Squibb Company, GSK Plc. are the key global market players in transthyretin amyloidosis (ATTR) market.
UAE Type 1 Diabetes Mellitus Drugs Market Analysis
UAE Type 1 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 1 Diabetes Mellitus Drugs market is growing globally due to the rising prevalence of type 1 diabetes mellitus, advancements in insulin therapies, technological advancements in insulin delivery systems, increasing focus on personalized medicine, rising healthcare expenditure, favorable reimbursement policies, increasing patient awareness and education, research and development initiatives and collaborations between pharmaceutical companies and academic institutions. Novo Nordisk, Eli Lilly and Company, Sanofi, Medtronic, Abbott Laboratories, Dexcom, Zealand Pharma, Xeris Pharmaceuticals, Insulet Corporation, and Tandem Diabetes Care are the key global market players in type 1 diabetes mellitus drugs market.
UAE Type 2 Diabetes Mellitus Drugs Market Analysis
UAE Type 2 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 2 Diabetes Mellitus Drugs market is growing globally due to the increasing prevalence of Type 2 diabetes, growing awareness and diagnosis about the disease, advancements in drug therapies, rising geriatric population, government initiatives and healthcare policies, technological advancements in drug delivery, increasing research and development activities and rising healthcare infrastructure. Novo Nordisk, Sanofi, Eli Lilly and Company, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Novartis International are the key global market players in type 2 Diabetes Mellitus Drugs Market.
UAE Tyrosine Kinase Inhibitors Market Analysis
UAE Tyrosine Kinase Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Tyrosine Kinase Inhibitors market is growing globally due to the Increasing prevalence of cancer, increasing use instead of conventional medicines due to their benefits, including the simplicity of oral administration, the capacity to target various cellular survival pathways, and the surge in demand for novel medications. The market is also influenced by an increase in pharmaceutical company investment and the utilization of cell processes to control different cell activities in cancer. Additionally, the market for tyrosine kinase inhibitors is positively impacted by increase in healthcare spending, awareness, population growth, increased healthcare infrastructure, and improvements in cancer treatments. F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Ascentage Pharma, AstraZeneca, Eisai Co., Ltd., Novartis AG, Sanofi, Bristol-Myers Squibb Company, Genentech, Inc., Pfizer Inc., Merck & Co., Inc., Suzhou Zelgen Biopharmaceuticals Co., Ltd., Celldex Therapeutics, Exelixis, Inc., Sino Biological Inc., AB Science, Bayer AG Deciphera Pharmaceuticals, Inc., and Johnson & Johnson Services, Inc are the key global market players in tyrosine kinase inhibitors market.
UAE Ulcerative Colitis Market Analysis
UAE Ulcerative Colitis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Ulcerative Colitis market is growing globally due to the increasing prevalence of ulcerative colitis, advancements in treatment options like introduction of biologic therapies, such as anti-TNF agents, anti-integrin agents and JAK inhibitors, rising awareness and diagnosis about disease, personalized medicine approaches, research and development initiatives, collaborations and partnerships between pharmaceutical companies and academic institutions. Johnson and Johnson, AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc., Novartis AG, Bausch Health Companies Inc. are the key global market players in ulcerative colitis market.
UAE Unresectable Hepatocellular Carcinoma Market Analysis
UAE Unresectable Hepatocellular Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Unresectable Hepatocellular Carcinoma market is growing globally due to the increasing incidence of unresectable hepatocellular carcinoma which is mainly due to rise in risk factors such as chronic hepatitis B and C infections, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and obesity. Advancements in diagnostic techniques like imaging techniques and biopsy, introduction of targeted therapies, immunotherapies, rising emphasis on combination therapies, clinical Trials and research initiatives. Bayer AG, Bristol Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., Ipsen Pharma, Merck & Co., Inc., Novartis International AG, Roche Holding AG, Sanofi S.A., Takeda Pharmaceutical Company Limited are the key global market players in unresectable hepatocellular carcinoma market.
UAE Urothelial Carcinoma Market Analysis
UAE Urothelial Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Urothelial Carcinoma market is growing globally due to the increasing incidence and prevalence of urothelial carcinoma due to aging population, smoking, exposure to certain chemicals, and chronic bladder inflammation, advancements in diagnostic techniques like urinary biomarkers, cystoscopy, development of novel therapies like targeted therapies or immune checkpoint inhibitors and increased focus on personalized medicine. AstraZeneca PLC, Bristol Myers Squibb Company, Eli Lilly and Company, Genentech, Inc. (a member of the Roche Group), Merck & Co., Inc., Novartis AG, Pfizer Inc., Seattle Genetics, Inc., Sanofi S.A., Johnson & Johnson are the key global market players in urothelial carcinoma market.
UAE Varicella Vaccine Market Analysis
UAE Varicella Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Varicella Vaccine market is growing globally due to the increasing vaccination coverage, growing public awareness about varicella vaccination, well established safety and efficacy profile of varicella vaccine, launch of varicella control programs by various governments. Merck & Co., Inc., GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Changchun BCHT Biotechnology Co., Ltd., Sinovac Biotech Ltd., Kaketsuken (Japan Blood Products Organization) and Shanghai Institute of Biological Products are the key global market players.
UAE Viscosupplementation Market Analysis
UAE Viscosupplementation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Viscosupplementation market is growing globally due to the increasing prevalence of osteoarthritis, growing aging population, and rising awareness about minimally invasive treatment options, increasing awareness and acceptance, technological advancements in viscosupplementation treatments, rise in the healthcare sector spending and infrastructure. Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V, sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS), APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW are the key global market players of viscosupplementation market.
UAE Vision Care Market Analysis
UAE Vision Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Vision Care market is growing globally due to the increasing prevalence of eye disorders such as myopia, hyperopia, astigmatism, and age-related macular degeneration (AMD), surging volume of patients suffering from chronic diseases which will led to the occurrences of vision ailments, improper intake of nutrition and unhealthy food eating habits, technological advancements in vision care industry like innovations in lens materials, frame designs, and contact lens technologies, increasing awareness about the importance of regular eye exams and eye health initiatives by governments, healthcare organizations and growth of the e-commerce sector. EssilorLuxottica, Johnson & Johnson, Novartis AG (Alcon), CooperVision, Bausch Health Companies (Bausch + Lomb), Zeiss, Hoya Corporation, Safilo Group and Carl Zeiss Meditec are the key global market players.
UAE Wearable Injectors Market Analysis
UAE Wearable Injectors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Wearable Injectors market is growing globally due to the strong healthcare infrastructure, rise in the incidence of lifestyle disorders, an ageing population that is more susceptible to diseases, increase in the desire for minimally invasive (MI) treatment alternatives, rise in chronic diseases like diabetes, autoimmune diseases, patient preference for self-administration medications in the comfort of their homes which enhances patient convenience, improves medication adherence, technological advancements in wearable injector technology which have improved device usability, functionality, patient experience. Continuous drug delivery provided by wearable injectors like more stable drug levels, reduced fluctuations, focus on patient centric care and cost-effective solutions provided by wearable injectors. Medtronic plc, Insulet Corporation, West Pharmaceutical Services, Inc., Enable Injections, SteadyMed Therapeutics, Inc., Sensile Medical AG, CeQur SA, Ypsomed AG, Becton, Dickinson and Company and Tandem Diabetes Care, Inc. are the key global market players in wearable injectors market.
UAE Anemia Therapeutics Market Analysis
The UAE Anemia Therapeutics Market is anticipated to experience a growth from $74 Mn in 2022 to $160 Mn by 2030, with a CAGR of 10.10% during the forecast period of 2022-2030. The UAE Anemia Therapeutics Market is driven by increased government efforts, research investments, pharmaceutical and delivery system advancements, increased healthcare awareness, and growing per capita income. The UAE Anemia Therapeutics Market encompasses various players across different segments, including Amgen, Roche, Novartis, Eli Lilly, GlycoMimetics, Apellis Pharmaceuticals, Life Pharma, Neo Pharma, New Bridge Pharmaceuticals, Sahara Pharmaceuticals, etc, among various others
UAE Dermatological Therapeutics Market Analysis
UAE Dermatological Therapeutics Market is at around $0.21 Bn in 2023 and is projected to reach $0.39 Bn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The market is being driven by advancements in dermatological research, medical tourism, and growing awareness of skin health. The market is dominated by key players like Neopharma, Julphur, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.
UAE Alopecia (Hair Loss) Therapeutics Market Analysis
The UAE Alopecia (Hair Loss) Therapeutics Market was valued at US $41 Mn in 2022, and is predicted to grow at (CAGR) of 8.5% from 2023 to 2030, to US $79 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of alopecia (hair loss), demographic changes, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Aclaris, Cipla, Follicum, Theradome, and Pfizer, among others
UAE Allergy Therapeutics Market Analysis
UAE allergy therapeutics market was valued at $116 Mn in 2022 and is estimated to reach $205 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The growing prevalence of allergic disorders and related medical issues is driving growth in the market for allergy treatment drugs. The top leading pharmaceutical companies operating in the market are Sanofi, GlaxoSmithKline (GSK), Novartis, Merck & Co., AstraZeneca, Bayer, Pfizer, Teva Pharmaceutical Industries, Almirall, and Chiesi Farmaceutici.
UAE Digital Therapeutics Market Analysis
UAE Digital Therapeutics Market is at around $31 Mn in 2023 and is projected to reach $176.43 Mn in 2030, exhibiting a CAGR of 28.2% during the forecast period. The market is being driven by rising rates of chronic diseases, technological advancements, and rising healthcare awareness. The market is dominated by key players like Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
UAE Alcohol Addiction Therapeutics Market Analysis
The UAE Alcohol Addiction Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $6 Mn by 2030, exhibiting a CAGR of 7.3% during the forecast period. The UAE Alcohol Addiction Therapeutic Market's market drivers include growing urbanization, social pressures in the workplace, and increased awareness of mental health problems, all of which contribute to increased alcohol intake. The key players involved in the research, development and distribution of Alcohol Addiction Therapeutics in UAE are GlaxoSmithKline, Lundbeck, TEVA, Roche, Eli Lilly, AstraZeneca, Cipla, Pfizer, Camden, Sun Pharmaceuticals, etc among others
UAE Cardiovascular Drugs Market Analysis
UAE Cardiovascular Drug Market is at around $0.67 Bn in 2022 and is projected to reach $1.01 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. Major reasons propelling the growth of this market are technological advancements, health insurance coverage, and partnerships with other pharmaceutical industries. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.
UAE Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the UAE Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UAE Vitamin and Minerals Market, offering unmatched value, accuracy, and expert insights.
UAE Vaccines Market Analysis
This report presents a strategic analysis of the UAE Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UAE vaccine market, offering unmatched value, accuracy, and expert insights.
UAE Rheumatology Drugs Market Analysis
UAE's Rheumatology Drugs Market is projected to grow from $305 Mn in 2022 to $411 Mn by 2030, registering a CAGR of 1.8% during the forecast period of 2022-30. The increasing prevalence of rheumatic diseases, such as rheumatoid arthritis and osteoarthritis, is driving growth in the UAE rheumatology drugs market. These diseases are becoming increasingly prevalent in the UAE due to the aging population and lifestyle-related factors, such as sedentary lifestyles and obesity. Pfizer is one of the leading pharmaceutical companies in the UAE, with a strong presence in the rheumatology drugs market. The company offers a range of rheumatology drugs, including biologic drugs and traditional disease-modifying antirheumatic drugs (DMARDs).
UAE Neurology Drugs Market Analysis
This report presents a strategic analysis of the UAE Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UAE Neurology Drugs Market, offering unmatched value, accuracy, and expert insights.
UAE Neurology Clinical Trials Market Analysis
UAE's Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $43.3 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the modern healthcare infrastructure and a favorable regulatory environment that encourages investment in clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer, and Biogen.
UAE Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The UAE Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $17 Mn in 2022 and is predicted to grow at (CAGR) of 8.8% from 2023 to 2030, to US $32 Mn by 2030. The key drivers of this industry include a healthcare infrastructure development by ongoing investments, international collaborations and partnerships with pharmaceuticals, increased awareness initiatives and other factors. The industry is primarily dominated by players such as Julphar, Neopharma, Medpharma, Novartis, Sanofi, Pfizer Inc, among other players
UAE Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The UAE Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $6 Mn in 2022, and is predicted to grow at (CAGR) of 6.8% from 2023 to 2030, to US $9 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, increased awareness, and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Reta, Regulus, and AceLink Therapeutics, among others